Diagnostic Industry Veteran Karin Eastham to Chair Personalis Board of Directors
Personalis’ oncology diagnostics business expected to build on foundation of advanced technology already the driver…
News
Statera Biopharma Announces Closing of $5.7 Million Underwritten Public Offering
FORT COLLINS, Colo., March 24, 2022 (GLOBE NEWSWIRE) — Statera Biopharma, Inc. (NASDAQ: STAB) (the…
Landos Biopharma Reports Fourth Quarter and Full Year 2021 Results and Provides Business Update
Continued Progress Towards Optimizing Clinical Development Plans On Track to Initiate Phase 2b Study of…
Correction: Galapagos publishes 2021 annual report and announces extraordinary and annual shareholders’ meetings
— Proposal of one-tier board structure & appointment of three new directors — Mechelen, Belgium;…
TFF Pharmaceuticals Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Business Update
Pipeline Advancement Continues with Ongoing Phase 2 Studies for Voriconazole and Tacrolimus Programs Partnership Activity…
Auxly to Report Fourth Quarter and Full Year 2021 Financial Results on March 31, 2022
TORONTO, March 24, 2022 (GLOBE NEWSWIRE) — Auxly Cannabis Group Inc. (TSX – XLY) (OTCQX:…
Kane Biotech Announces Fourth Quarter and Full Year 2021 Financial Results
WINNIPEG, Manitoba, March 24, 2022 (GLOBE NEWSWIRE) — Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (the…
Imago BioSciences Reports Fourth Quarter and Full Year 2021 Financial Results
SOUTH SAN FRANCISCO, Calif., March 24, 2022 (GLOBE NEWSWIRE) — Imago BioSciences, Inc. (“Imago”) (Nasdaq:…
Bellicum Reports Fourth Quarter 2021 Financial Results and Provides Operational Update
– Confirmed partial response in one of the first three metastatic castration-resistant prostate cancer (mCRPC)…
SeqLL to Participate in the 2022 Virtual Growth Conference Presented by Maxim Group LLC and hosted by M-Vest
BILLERICA, Mass., March 24, 2022 (GLOBE NEWSWIRE) — SeqLL Inc. (“SeqLL” or the “Company”) (NASDAQ:…
GBT Announces Participation at the Guggenheim Genomic Medicines & Rare Disease Day
SOUTH SAN FRANCISCO, Calif., March 24, 2022 (GLOBE NEWSWIRE) — Global Blood Therapeutics, Inc. (GBT) (NASDAQ:…
Athira Pharma Reports Full Year 2021 Financial Results and Provides Clinical Update
On track to report topline data from ACT-AD Phase 2 Alzheimer’s disease study in 2Q22…
Panbela Provides Business Update and Reports Q4 and FY 2021 Financial Results
MINNEAPOLIS, March 24, 2022 (GLOBE NEWSWIRE) — Panbela Therapeutics, Inc. (Nasdaq: PBLA), a clinical stage company developing…
Erasca Reports Fourth Quarter 2021 Financial Results and Business Updates
Five ongoing clinical trials evaluating candidates ERAS-007 (ERKi), ERAS-601 (SHP2i), and ERAS-801 (CNS-penetrant EGFRi) Initial…
89bio Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Corporate Update
– Reported positive topline results from cohort 7 in the Phase 1b/2a trial including data from…
ADMA Biologics Announces Fourth Quarter and Full Year 2021 Financial Results and Provides Business Update, Including $175M Debt Refinance with Hayfin Capital Management
Full Year 2021 Total Revenues of Approximately $81 Million, a 92% Increase Over Full Year…
Eledon Pharmaceuticals Reports Fourth Quarter and Full-Year 2021 Operating and Financial Results
Topline data from Phase 2a trial of tegoprubart in ALS expected in 2Q 2022 Ongoing…
Vaxxinity Reports Fourth Quarter and Full-Year 2021 Financial Results and Provides Corporate Updates
DALLAS, March 24, 2022 (GLOBE NEWSWIRE) — Vaxxinity, Inc. (Nasdaq: VAXX), a U.S. company pioneering…
Galapagos publishes 2021 annual report and announces extraordinary and annual shareholders’ meetings
— Proposal of one-tier board structure & appointment of three new directors — Mechelen, Belgium;…
Study in Modern Optometry Shows Effectiveness Of Merakris Therapeutics’ Eye Product, Opticyte® Matrix
RESEARCH TRIANGLE PARK, N.C., March 24, 2022 (GLOBE NEWSWIRE) — Opticyte® Amniotic Ocular Matrix, a…